Development Level

Tbio 8 | 10,625
Tchem 2 | 1,890
Tclin 1 | 602

Disease

osteosarcoma 9 | 7,933
psoriasis 8 | 6,685
Cancer 7 | 2,346
glioblastoma 5 | 5,572
lung cancer 5 | 4,466
medulloblastoma, large-cell 5 | 6,234
oligodendroglioma 5 | 2,849
ovarian cancer 5 | 8,484
primitive neuroectodermal tumor 5 | 3,031
ulcerative colitis 5 | 2,087
Acquired immunodeficiency syndrome 4 | 164
Chronic Lymphocytic Leukemia 4 | 242
Rheumatoid Arthritis 4 | 1,160
atypical teratoid / rhabdoid tumor 4 | 4,369
ductal carcinoma in situ 4 | 1,745
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,956
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,289
invasive ductal carcinoma 4 | 2,950
malignant mesothelioma 4 | 3,162
Anemia 3 | 252
Lymphoma 3 | 56
Thrombocytopenia 3 | 105
astrocytoma 3 | 1,493
interstitial cystitis 3 | 2,299
lung carcinoma 3 | 2,844
nasopharyngeal carcinoma 3 | 1,056
pancreatic cancer 3 | 2,300
pilocytic astrocytoma 3 | 3,086
posterior fossa group A ependymoma 3 | 1,511
subependymal giant cell astrocytoma 3 | 2,287
tuberculosis 3 | 1,557
Adenoma 2 | 165
Bladder Neoplasm 2 | 109
Breast cancer 2 | 3,094
Chromosome Breakage 2 | 5
Colonic Neoplasms 2 | 126
Common variable immunodeficiency 2 | 72
Endometriosis 2 | 535
Familial adenomatous polyposis 2 | 31
Hemangiosarcoma 2 | 18
Hypertensive disease 2 | 193
Hypertrophic Cardiomyopathy 2 | 56
Leukemia, Myelocytic, Acute 2 | 113
Leukopenia 2 | 42
Liver Neoplasms, Experimental 2 | 48
Liver carcinoma 2 | 217
Liver neoplasms 2 | 109
Lung Neoplasms 2 | 171
Lymphoid leukemia 2 | 69
Lymphoma, Non-Hodgkin 2 | 22
Lymphoma, T-Cell, Cutaneous 2 | 21
Mammary Neoplasms 2 | 410
Multiple myeloma 2 | 1,327
Neoplasm Metastasis 2 | 138
Neoplastic Cell Transformation 2 | 81
Neurodegenerative disease 2 | 383
Nijmegen breakage syndrome 2 | 23
Pancreatic Neoplasm 2 | 79
Prostatic Neoplasms 2 | 471
Stomach Neoplasms 2 | 282
T-Cell Lymphoma 2 | 11
Urinary bladder cancer 2 | 31
adrenocortical carcinoma 2 | 1,427
astrocytic glioma 2 | 2,241
breast carcinoma 2 | 1,614
diabetes mellitus 2 | 1,663
ependymoma 2 | 2,514
group 3 medulloblastoma 2 | 2,254
group 4 medulloblastoma 2 | 1,875
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
non diabetic and post-ischemic heart failure 2 | 200
non-small cell lung carcinoma 2 | 413
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
pediatric high grade glioma 2 | 2,712
pituitary cancer 2 | 1,972
primary Sjogren syndrome 2 | 789
sonic hedgehog group medulloblastoma 2 | 1,482
Acute Megakaryocytic Leukemias 1 | 4
Adrenal Gland Neoplasms 1 | 11
Balkan Nephropathy 1 | 6
Carotid Artery Diseases 1 | 11
Demyelinating Diseases 1 | 7
Genitourinary Neoplasms 1 | 3
Hemangioma 1 | 35
Hepatoblastoma 1 | 17
Ischemia 1 | 27
Keratosis 1 | 34
Large intestine cancer 1 | 12
Liver Diseases, Parasitic 1 | 9
Lymphatic system disease 1 | 14
Mouth Neoplasms 1 | 42
Neurofibromatosis 1 | 37
Pathological accumulation of air in tissues 1 | 11
Penile Neoplasms 1 | 4
Skin Neoplasms 1 | 49
Tetanus 1 | 66
Thymoma 1 | 16
Vulvar Lichen Sclerosus 1 | 2
Xeroderma pigmentosum 1 | 41
gallbladder neoplasm 1 | 9

Tissue

Blood and immune system 11 | 17,995
Cardiovascular System 11 | 17,958
Digestive Tract 11 | 18,473
Endocrine System 11 | 18,512
Female tissues 11 | 18,647
Liver and Pancreas 11 | 18,136
Male tissues 11 | 17,969
Nervous System 11 | 18,561
Respiratory system 11 | 17,484
Skin and soft tissues 11 | 18,115
Urinary Tract 11 | 18,444

Target Family

Non-IDG 4 | 11,971
Transcription Factor 4 | 1,400
Enzyme 2 | 4,146
Epigenetic 1 | 242

Grant Application

5P01CA092625-08 11 | 11
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Tumor necrosis factor receptor superfamily member 13C TNFRSF13C Tbio Non-IDG -2.19014 146.3 349
Gamma-interferon-inducible lysosomal thiol reductase IFI30 Tbio Enzyme -2.10661 141.4 103
Myc proto-oncogene protein MYC Tbio Transcription Factor -4.07639 11730.8 2241
Cellular tumor antigen p53 TP53 Tchem Transcription Factor -4.67490 51004.8 5255
DNA repair protein XRCC4 XRCC4 Tbio Non-IDG -2.35047 222.7 297
PWWP domain-containing protein MUM1 MUM1 Tbio Epigenetic -0.61979 4.70 125
Interferon regulatory factor 4 IRF4 Tbio Transcription Factor -2.44177 329.8 476
Histone H2AX H2AFX Tbio Non-IDG -3.19144 1458.2 841
Glucosylceramidase GBA Tchem Enzyme -3.16115 1484.2 216
T-cell surface antigen CD2 CD2 Tclin Non-IDG -3.31938 2389.8 1256